Application of elaeagnus mollis and elaeagnus mollis extract in preparation of weight-losing and lipid-lowering medicine or health

The preparation of weight loss and lipid-reducing drugs or health products through the extract of phthalia vine has solved the problems of low efficacy and major side effects in the existing obesity treatment methods, and achieved effective weight loss and blood lipid improvement effects.

CN119015334APending Publication Date: 2024-11-26SOUTHWEST UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411231788.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-04
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing methods for treating obesity have problems with difficulty in persisting in long-term exercise and low efficacy and major side effects of anti-obesity drugs. There is a lack of effective, safe and easy-to-persist in weight loss and lipid reduction strategies.

Method used

The extract from the whole grass, fruit, roots and stems of the winged fruit vine is prepared by hydrophilic organic solvent extraction method, which is used to prepare weight loss and lipid-reducing drugs or health products, including suspensions , granules and other dosage forms, and pharmaceutically acceptable auxiliary materials can be added.

Benefits of technology

The extract of winged fruit vine significantly reduces the weight of mice, inhibits fat cell growth, improves abnormal blood lipids and sugar metabolism, and does not affect appetite and food consumption, providing an effective and safe weight loss and lipid reduction effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015334A_ABST
    Figure CN119015334A_ABST
Patent Text Reader

Abstract

The invention discloses application of elaeagnus mollis and an extract of the elaeagnus mollis in preparation of weight-losing and lipid-lowering medicines or health-care products, and further discloses the elaeagnus mollis extract which is prepared by the following steps: cleaning, drying and crushing the elaeagnus mollis, extracting the crushed elaeagnus mollis by using a hydrophilic organic solvent, collecting an extracting solution, and concentrating the extracting solution to obtain the elaeagnus mollis extract. The invention not only can promote the comprehensive development and utilization and industrial development of the elaeagnus mollis, but also provides an effective and safe new medicine or health care product for losing weight and lowering lipid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medicines and relates to application of serrata pterocarpa and an extract thereof in preparing medicines or health products. Background Art

[0002] The World Health Organization considers overweight and obesity to be excessive and abnormal fat deposition, which is harmful to health and has become an increasingly worsening global public health challenge, which is usually characterized by fat accumulation, dyslipidemia, oxidative stress, systemic low-grade inflammation and intestinal microbiome disorders. Recent reports show that overweight and obesity account for 34.3% and 16.4% of Chinese adults, respectively. More seriously, overweight and obesity are becoming younger, and it is estimated that by 2030, 254 million children and adolescents worldwide will suffer from obesity. Obesity not only brings great pain to individuals and society, but also increases the risk of other diseases, such as type 2 diabetes, non-alcoholic fatty liver disease, dyslipidemia, cardiovascular disease, sleep disorders, COVID-19 and cancer. The main means of treating obesity at present are dieting (reducing energy intake), long-term exercise, drug therapy (such as amphetamines, orlistat, sibutramine, etc.), surgery (such as gastric bypass and gastroplasty) and psychotherapy. Given the difficulty in maintaining long-term exercise, as well as the low efficacy and significant side effects of anti-obesity drugs, it is of great significance to study alternative strategies for alleviating obesity that are effective, safe, and easy to adhere to.

[0003] Myriopteron extensum (Wight) K. Schum is a plant of the genus Myriopteron of the Asclepiadaceae family. It is mainly distributed in Guizhou, Yunnan and Guangxi, and grows in sparse forests or shrubs at an altitude of 600 to 1,600 meters. Myriopteron extensum is included in the "National Collection of Chinese Herbal Medicines" and "Yunnan Chinese Herbal Medicines". Its root is used as medicine, which has the effects of tonifying the middle and replenishing qi, relieving cough, and regulating menstruation. It is mainly used to treat colds, coughs, menorrhagia, uterine prolapse, and rectal prolapse; the whole plant can treat tuberculosis. In addition to the above effects, Myriopteron extensum also has extremely high edible value. The fruit of Myriopteron extensum contains a variety of mineral elements, such as phosphorus, iron, calcium, magnesium, sodium, etc. Its phosphorus and iron content is between that of apples and leeks; although the calcium content is lower than that of leeks, it is far higher than that of zucchini and apples, and has a high calcium supplement value; the magnesium content is 6 times that of apples, which is not much different from that of leeks; the sodium content is only about 1 / 14 of that of leeks, and it is a low-sodium food. The fruit of the samara vine contains a variety of free amino acids, the total amount of which is higher than that of pitaya and kiwi fruit, and the content is as high as 6.5 times that of kiwi fruit; it also contains all other essential amino acids for the human body except threonine and lysine, and the proportion of essential amino acids in the total amount is relatively high (61.24%), which is 3.6 times that of pitaya and 1.7 times that of kiwi fruit. At the same time, the samara vine also contains a variety of natural non-sugar high-sweetness compounds, the sweetness of which ranges from 25 to 400 times that of sucrose, with the advantages of high sweetness and low calories. Summary of the invention

[0004] One of the purposes of the present invention is to provide an application of Samara vine and its extract in the preparation of weight loss and lipid-lowering drugs or health products. The second purpose is to provide a Samara vine extract, which not only promotes the comprehensive development and utilization of Samara vine and its industrial development, but also provides an effective and safe new drug or health product for weight loss and lipid-lowering.

[0005] After research, the present invention provides the following technical solutions:

[0006] 1. Application of Wingnut vine in the preparation of weight loss and lipid-lowering drugs or health products.

[0007] Furthermore, the Samara vine is any one or more of the whole herb, fruit, root, stem and leaf of Samara vine.

[0008] 2. Application of the extract of Pteris serrata in the preparation of weight loss and lipid-lowering drugs or health products.

[0009] Furthermore, the Samara vine is any one or more of the whole herb, fruit, root, stem and leaf of Samara vine.

[0010] 3. A serrata serrata extract is prepared by the following method: washing, drying, and crushing the serrata serrata, extracting with a hydrophilic organic solvent, collecting the extract, and concentrating to obtain the serrata serrata extract.

[0011] Furthermore, the Samara vine is any one or more of the whole herb, fruit, root, stem and leaf of Samara vine.

[0012] Furthermore, the hydrophilic organic solvent is any one or more of ethanol, methanol and acetone.

[0013] Furthermore, the method is to wash, dry and crush the serrata to obtain dry powder, add a hydrophilic organic solvent to soak, heat and reflux to extract 2-3 times, each time the solid-liquid ratio is 1:5-1:10, extract for 2-3 hours, collect the extract, combine, and concentrate at 60°C to obtain the serrata extract.

[0014] The dosage forms of the weight loss and lipid-lowering medicine or health product of the present invention include, but are not limited to, suspensions, granules, capsules, powders, tablets, emulsions, solutions, pills, and drops.

[0015] The weight loss and lipid-lowering medicine or health product of the present invention may also contain one or more pharmaceutically acceptable excipients, including but not limited to: carriers, diluents, excipients, fillers, adhesives, wetting agents, disintegrants, emulsifiers, cosolvents, solubilizers, surfactants, coating materials, colorants, pH regulators or buffers.

[0016] The research results of the present invention confirm that the extracts of different parts of the serrata vine (fruit, root, stem and leaf) can significantly reduce the weight gain of mice without affecting the normal food and energy intake of mice; the serrata vine fruit extract can significantly inhibit the weight gain of mice, inhibit the enlargement of mouse fat cells caused by high-fat diet, significantly reduce the content of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) in mouse serum, significantly increase the content of high-density lipoprotein cholesterol (HDL-C) in mouse serum, and improve the abnormal glucose metabolism and impaired glucose tolerance of mice, but do not affect the appetite and food intake of mice. Therefore, the serrata vine and its extract have obvious weight loss and lipid-lowering effects, and can be used to prepare weight loss and lipid-lowering drugs or health products.

[0017] The beneficial effects of the present invention are as follows: the present invention provides the use of Wingnut vine and its extract in the preparation of weight loss and lipid-lowering drugs or health products, and also provides a Wingnut vine extract, which has a simple preparation method and can not only promote the comprehensive development and utilization of Wingnut vine and its industrial development, but also provide an effective and safe new drug or health product for weight loss and lipid-lowering. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is the curve of body weight changes in mice during administration of extracts from different parts of Psoralea corylifolia.

[0019] Figure 2 This study is about the effects of extracts from different parts of Sambaria serrata on the food intake of mice.

[0020] Figure 3 To investigate the effects of extracts from different parts of Psoralea corylifolia on the energy intake of mice.

[0021] Figure 4 This is the curve of body weight changes in mice during administration of the ethanol extract of Psoralea corylifolia fruit.

[0022] Figure 5 The effect of the ethanol extract of the fruit of Sambaria serrata on the weight gain of mice.

[0023] Figure 6 The effect of the ethanol extract of Psoralea corylifolia fruit on the Lee's index of mice.

[0024] Figure 7 The effect of the ethanol extract of the fruit of Sambaria serrata on the food intake of mice.

[0025] Figure 8 Effect of ethanol extract of Psoralea corylifolia fruit on energy intake in mice.

[0026] Fig. 9 To investigate the effect of the ethanol extract of Psoralea corylifolia fruit on the mass of inguinal white adipose tissue (iWAT) in mice.

[0027] Fig.10 To investigate the effect of the ethanol extract of Psoralea corylifolia fruit on the mass of retroperitoneal white adipose tissue (rWAT) in mice.

[0028] Fig.11 To investigate the effect of the ethanol extract of Psoralea corylifolia fruit on the mass of epididymal white adipose tissue (eWAT) in mice.

[0029] Fig.12 Effect of the ethanol extract of the fruit of Pteris ternata on the liver quality of mice.

[0030] Fig.13 Effects of the ethanol extract of Pteris serrata fruit on adipose tissue pathology in mice.

[0031] Fig.14 This is the effect of the ethanol extract of the fruit of Psoralea corylifolia on TC in mouse serum.

[0032] Fig.15 This is the effect of the ethanol extract of the fruit of Psoralea corylifolia on TG in mouse serum.

[0033] Fig.16 This study is about the effect of the ethanol extract of the fruit of Pteris serrata on the LDL-C in the serum of mice.

[0034] Fig.17 This study is about the effect of the ethanol extract of the fruit of Pteris salsa on the HDL-C in the serum of mice.

[0035] Fig.18 To investigate the effect of the ethanol extract of Psoralea corylifolia fruit on glucose metabolism in mice.

[0036] Fig.19 To investigate the effect of the ethanol extract of Psoralea corylifolia fruit on oral glucose tolerance in mice.

[0037] In the above figures, ND is the normal control group, HFD is the high-fat model group, OR is the orlistat positive control group, MEFE is the group administered with ethanol extract of the fruit of Psoralea corylifolia, MERM is the group administered with methanol extract of the root of Psoralea corylifolia, MESA is the group administered with acetone extract of the stem and leaf of Psoralea corylifolia, L-MEFE is the group with low-dose ethanol extract of the fruit of Psoralea corylifolia, and H-MEFE is the group with high-dose ethanol extract of the fruit of Psoralea corylifolia; compared with the ND group, # P<0.05, ## P<0.01, ### P < 0.001, #### P<0.0001; compared with the HFD group, * P<0.05, ** P<0.01, *** P < 0.001, **** P<0.0001. DETAILED DESCRIPTION

[0038] In order to make the objectives, technical solutions and beneficial effects of the present invention more clear, preferred embodiments of the present invention are described in detail below.

[0039] Example 1. Preparation of ethanol extract of Psoralea corylifolia fruit

[0040] Collect the fruits of Samara vine, wash, dry, and grind to obtain dry powder, put it in an extraction tank, add anhydrous ethanol to soak, heat reflux extraction 3 times, each time with a solid-liquid ratio of 1:5, extract for 2 hours, collect the filtrate, combine the filtrates of 3 times, and concentrate to 1g / mL in a rotary evaporator at 60℃ to obtain the ethanol extract of Samara vine fruit.

[0041] Example 2. Preparation of methanol extract from the root of Psoralea corylifolia

[0042] The roots of Samara vine were collected, washed, dried, and crushed to obtain dry powder, placed in an extraction tank, soaked in methanol, and extracted by heating under reflux for 3 times, each time with a solid-liquid ratio of 1:8, and extracted for 2 hours. The filtrate was collected, the filtrates were combined, and concentrated to 1 g / mL in a rotary evaporator at 60°C to obtain the methanol extract of Samara vine roots.

[0043] Example 3. Preparation of acetone extract of stems and leaves of Samara serrata

[0044] Collect the stems and leaves of Samara vine, wash, dry, and grind to obtain dry powder, put it in an extraction tank, add acetone to soak, heat reflux extraction 3 times, each time the solid-liquid ratio is 1:10, extract for 2 hours, collect the filtrate, combine the filtrates of 3 times, and concentrate to 1g / mL in a rotary evaporator at 60℃ to obtain the acetone extract of Samara vine stems and leaves.

[0045] Example 4. Study on the weight loss effect of extracts from different parts of Psoralea corylifolia on high-fat mice

[0046] Experimental animals: SPF-grade C57BL / 6J male mice, weighing 18-22 g, were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd., license number: SCXK (Xiang) 2019-0004.

[0047] Animal housing conditions: 4-5 mice per cage, free access to water and food; room temperature 22-27°C, relative humidity 50-60%, day and night light / dark alternation 12h / 12h.

[0048] Animal feed: ordinary feed (including high-quality corn, high-quality wheat, puffed soybean meal, high-quality alfalfa meal), high-fat feed (including 18% sucrose, 20% lard, 49% maintenance feed, 9% casein, 2.4% premix, 1.6% maltodextrin).

[0049] Establishment of high-fat model: After one week of adaptation, 10 C57BL / 6J male mice were randomly selected as the normal control group (ND) and fed with ordinary feed daily; the remaining mice were fed with high-fat feed daily. After 2 weeks of feeding, 30% of the obesity-resistant mice were eliminated according to the weight of the mice, and the remaining mice continued to be fed with high-fat feed for 6 weeks to establish the obese mouse model (the weight difference between obese mice and normal control mice was greater than 20% of the weight of normal control mice).

[0050] Obese mice were randomly divided into 5 groups. The specific groups and experimental conditions are as follows:

[0051] High-fat diet model group (HFD): fed with high-fat diet and intragastrically administered with the same amount of sterile saline every day;

[0052] Orlistat positive control group (OR): fed with high-fat diet and intragastrically administered with orlistat 27.3 mg / kg per day;

[0053] The group receiving ethanol extract of the fruit of the serrata var. salsa (MEFE) was fed with a high-fat diet and intragastrically administered 300 mg / kg of ethanol extract of the fruit of the serrata var. salsa every day.

[0054] The group treated with methanol extract of Sambarella root (MERM) was fed with high-fat diet and intragastrically administered with 300 mg / kg methanol extract of Sambarella root every day.

[0055] The group treated with acetone extract of stems and leaves of Samara serrata (MESA) was fed with a high-fat diet and intragastrically administered with 300 mg / kg acetone extract of stems and leaves of Samara serrata every day.

[0056] Meanwhile, the ND group was fed with normal feed and gavaged with the same amount of sterile saline every day.

[0057] The above 6 groups were gavaged once a day for 4 consecutive weeks. During the experiment, each group of mice was housed in a single cage, with a room temperature of 25±2℃ and a humidity of 55±5%, and a 12-hour day and night light and dark alternation in the room. The mice were free to eat and drink.

[0058] Sample collection, testing indicators and methods: The amount of food given and the amount of food left over were recorded daily, and the food intake of mice was calculated as the amount of food given the previous day minus the amount of food left over today. The weight of mice was recorded weekly.

[0059] Test results:

[0060] like Figure 1-Figure 3 As shown, compared with the HFD group, after 4 weeks of administration, the MEFE group, MERM group and MESA group all significantly reduced the weight gain of mice without affecting the normal food and energy intake of the mice.

[0061] Example 5. Study on the weight loss and lipid-lowering effect of the ethanol extract of the fruit of the serrata var. salsa on high-fat mice

[0062] Experimental animals: SPF-grade C57BL / 6J male mice, weighing 18-23 g, were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd., license number: SCXK (Xiang) 2019-0004.

[0063] Animal housing conditions: 4-5 mice per cage, free access to water and food; room temperature 22-27°C, relative humidity 50-60%, day and night light / dark alternation 12h / 12h.

[0064] Animal feed: ordinary feed (including high-quality corn, high-quality wheat, puffed soybean meal, high-quality alfalfa meal), high-fat feed (including 18% sucrose, 20% lard, 49% maintenance feed, 9% casein, 2.4% premix, 1.6% maltodextrin).

[0065] Establishment of high-fat model: After one week of adaptation, 10 C57BL / 6J male mice were randomly selected as the normal control group (ND) and fed with ordinary feed daily; the remaining mice were fed with high-fat feed daily. After 2 weeks of feeding, 30% of the obesity-resistant mice were eliminated according to the weight of the mice, and the remaining mice continued to be fed with high-fat feed for 6 weeks to establish the obese mouse model (the weight difference between obese mice and normal control mice was greater than 20% of the weight of normal control mice).

[0066] Obese mice were randomly divided into 4 groups. The specific groups and experimental conditions are as follows:

[0067] High-fat diet model group (HFD): fed with high-fat diet and intragastrically administered with the same amount of sterile saline every day;

[0068] Orlistat positive control group (OR): fed with high-fat diet and intragastrically administered with orlistat 27.3 mg / kg per day;

[0069] Low-dose group of ethanol extract of the fruit of Samara serrata (L-MEFE): fed with high-fat diet, and intragastric administration of 150 mg / kg ethanol extract of the fruit of Samara serrata per day;

[0070] High-dose group of ethanol extract of the fruit of the samara vine (H-MEFE): fed with high-fat diet, 300 mg / kg of ethanol extract of the fruit of the samara vine was administered orally every day;

[0071] Meanwhile, the ND group was fed with normal feed and gavaged with the same amount of sterile saline every day.

[0072] The above five groups were gavaged once a day for four weeks. During the experiment, each group of mice was housed in a single cage, with a room temperature of 25±2℃ and a humidity of 55±5%, and a 12-hour light-dark cycle in the room. The mice were free to eat and drink.

[0073] Sample collection, detection indicators and methods: The amount of food given and the amount of food left over were recorded daily, and the food intake of mice was calculated. The food intake was the amount of food given the previous day minus the amount of food left over today. The weight and length of mice were recorded weekly, and the Lee's index of mice was calculated. After 4 weeks of administration, at the end of the experiment, the overnight fasted mice were given oral glucose 2g / kg. After 0, 30, 60, 90, and 120 minutes of oral glucose, blood was collected from the tail vein, and the blood glucose level was measured with a blood glucose meter. The area under the curve (AUC) was calculated to evaluate glucose tolerance. After the last administration, the mice fasted for 12 hours, the eyeballs were removed to collect blood, and the blood was allowed to stand at room temperature for 30 minutes, then centrifuged at 4000rpm for 10 minutes, and the supernatant (serum) was taken. Finally, the mice were killed by cervical dislocation, and the liver and white adipose tissue were separated, weighed, and collected. All samples were stored at -80°C for subsequent analysis.

[0074] One-way analysis of variance (ANOVA) and Fisher's least significant difference (LSD) test were used to analyze the statistical significance among the groups.

[0075] Test results:

[0076] (1) Effects of Pteris serrata extract on body weight and food intake of mice

[0077] like Figure 4-Figure 6 As shown in Figure 2, compared with the HFD group, after 4 weeks of administration, both the L-MEFE group and the H-MEFE group significantly reduced the weight gain and Lee's index of the mice without affecting the normal food and energy intake of the mice ( Figure 7-Figure 8 ).

[0078] (2) Effects of Pteris serrata extract on white adipose tissue and liver mass in mice

[0079] like Figure 9-12 As shown in the figure, compared with the HFD group, the L-MEFE group and the H-MEFE group could significantly reduce the weight of iWAT, rWAT, eWAT and liver tissue of mice, and within 4 weeks of administration, the volume of fat cells in the HFD group increased, while the L-MEFE group and the H-MEFE group could significantly reduce the volume of fat cells in mice ( Fig.13 ).

[0080] (3) Effects of the extract of Pteris pterocarpa on four blood lipids in mouse serum

[0081] like Figure 14-17 As shown, after 4 weeks of administration, compared with the HFD group, the L-MEFE group and the H-MEFE group could significantly reduce the levels of TC, TG, and LDL-C in the serum of mice, and at the same time significantly increase the level of HDL-C in the serum of mice.

[0082] (4) Effect of Pteris serrata extract on glucose metabolism in mice

[0083] like Figure 18-19 As shown in the results, compared with the HFD group, both the L-MEFE group and the H-MEFE group could significantly improve the abnormal glucose metabolism and impaired glucose tolerance of mice induced by high-fat diet.

[0084] Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that various changes can be made in form and details without departing from the scope defined by the claims of the present invention.

Claims

1. Application of Wingnut vine in the preparation of weight loss and lipid-lowering drugs or health products.

2. The use of the Sambara serrata as claimed in claim 1 in the preparation of weight loss and lipid-lowering drugs or health products, characterized in that: The samara vine is any one or more of the whole herb, fruit, root, stem and leaf of samara vine.

3. Application of the extract of Pteris serrata in the preparation of weight loss and lipid-lowering drugs or health products.

4. The use of the extract of Psoralea corylifolia as claimed in claim 3 in the preparation of weight loss and lipid-lowering drugs or health products, characterized in that: The samara vine is any one or more of the whole herb, fruit, root, stem and leaf of samara vine.

5. A serrata serrata extract, characterized in that: The preparation method is as follows: washing, drying and crushing the samaragorn vine, extracting with a hydrophilic organic solvent, collecting the extract and concentrating it to obtain the samaragorn vine extract.

6. The extract of claim 5, characterized in that: The samara vine is any one or more of the whole herb, fruit, root, stem and leaf of samara vine.

7. The extract of claim 5, characterized in that: The hydrophilic organic solvent is any one or more of ethanol, methanol and acetone.

8. The extract of claim 5, characterized in that: The method comprises the following steps: washing, drying and crushing the serrata var. salsa to obtain dry powder, adding a hydrophilic organic solvent for soaking, heating and refluxing for extraction 2-3 times, each time with a solid-liquid ratio of 1:5-1:10, extracting for 2-3 hours, collecting the extracts, combining them, and concentrating them at 60°C to obtain the serrata var. salsa extract.

Citation Information

Patent Citations

  • Compounds of natural sweetening agent C-21 steroid saponinand category and preparation methods and application thereof

    CN104926907A

  • Vine leaf extract and its preparation process

    CN1475222A